These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2930998)

  • 41. A double-blind study comparing paroxetine and maprotiline in depressed outpatients.
    Szegedi A; Wetzel H; Angersbach D; Dunbar GC; Schwarze H; Philipp M; Benkert O
    Pharmacopsychiatry; 1997 May; 30(3):97-105. PubMed ID: 9211571
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Double-blind comparison of the effects of a new tricyclic antidepressant (Lofepramine) and a tetracyclic antidepressant (maprotiline)].
    Obermair W; Pöldinger W
    Int Pharmacopsychiatry; 1977; 12(2):65-71. PubMed ID: 330440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dexamethasone suppression test and the response to antidepressant depending on their central monoaminergic action in major depression.
    Benkelfat C; Poirier MF; Léouffre P; Gay C; Löo H
    Can J Psychiatry; 1987 Apr; 32(3):175-8. PubMed ID: 3471304
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical considerations regarding the use of maprotiline in psychiatric treatment].
    Pirozynski T; Chiriţă V; Mungiu OC; Cosmovici N; Boişteanu P
    Rev Med Chir Soc Med Nat Iasi; 1987; 91(2):251-5. PubMed ID: 3685686
    [No Abstract]   [Full Text] [Related]  

  • 45. The antidepressant efficacy of zimelidine and maprotiline.
    Montgomery SA; Rani SJ; McAuley R; Roy D; Montgomery DB
    Acta Psychiatr Scand Suppl; 1981; 290():219-24. PubMed ID: 6452792
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparison of maprotiline (Ludiomil) and amitriptyline (2).
    Mindham BA
    J Int Med Res; 1977; 5 Suppl 4():25-33. PubMed ID: 338399
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oxaprotiline in the treatment of endogenous depressed inpatients an early clinical trial.
    Schmauss M; Laakmann G; Dieterle D; Blaschke D
    Pharmacopsychiatry; 1985 Jul; 18(4):282-5. PubMed ID: 3895255
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The new antidepressant zimeldine in general practice. A surveillance study of 15,000 patients.
    Fünfgeld EW
    Acta Psychiatr Scand Suppl; 1983; 308():96-103. PubMed ID: 6230899
    [TBL] [Abstract][Full Text] [Related]  

  • 49. CGP 12.103 A versus clomipramine in the treatment of depressed inpatients--results of a double-blind study.
    Wolfersdorf M; Wendt G; Binz U; Steiner B; Hole G
    Pharmacopsychiatry; 1988 Jul; 21(4):203-7. PubMed ID: 3060885
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A double-blind comparative trial of zimelidine, amitriptyline, and placebo in patients with mixed anxiety and depression.
    Amsterdam JD; Case WG; Csanalosi E; Singer M; Rickels K
    Pharmacopsychiatry; 1986 May; 19(3):115-9. PubMed ID: 2941771
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Double-bind comparison of maprotiline with amitriptyline in the treatment of depressive illness.
    Trick KL
    Int Pharmacopsychiatry; 1975; 10(4):193-8. PubMed ID: 765292
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemistry, pharmacology, pharmacokinetics, adverse effects, and efficacy of the antidepressant maprotiline hydrochloride.
    Wells BG; Gelenberg AJ
    Pharmacotherapy; 1981; 1(2):121-39. PubMed ID: 6765485
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Maprotiline in the treatment of endogenous depression: comparison of therapeutic effect with serotonin level in blood platelets.
    Mück-Seler D; Deanović Z; Jamnicky B; Jakupcević M; Mihovilović M
    Psychopharmacology (Berl); 1983; 79(2-3):262-5. PubMed ID: 6189139
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute effects of maprotiline, doxepin and zimeldine with alcohol in healthy volunteers.
    Strömberg C; Seppälä T; Mattila MJ
    Arch Int Pharmacodyn Ther; 1988; 291():217-28. PubMed ID: 2966613
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Our experiences in the treatment of pharmacoresistent depressions with maprotiline].
    Rektor L; Misaurec J; Horká E; Cerná V
    Act Nerv Super (Praha); 1982 May; 24(2):101-5. PubMed ID: 7102221
    [No Abstract]   [Full Text] [Related]  

  • 56. Cognitive and psychomotor effects of different antidepressants in the treatment of old age depression.
    Siegfried K; O'Connolly M
    Int Clin Psychopharmacol; 1986 Jul; 1(3):231-43. PubMed ID: 3549874
    [No Abstract]   [Full Text] [Related]  

  • 57. Pharmacological specificity is not the same as clinical selectivity.
    Montgomery SA; James D; Montgomery DB
    Psychopharmacol Ser; 1987; 3():179-83. PubMed ID: 2434946
    [No Abstract]   [Full Text] [Related]  

  • 58. Zimeldine in depressive illness--efficacy and safety data.
    Burrows GD; Norman TR; Marriott PF; Davies B
    Acta Psychiatr Scand Suppl; 1983; 308():31-40. PubMed ID: 6230894
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma tryptophan and tyrosine ratios to competing amino acids in relation to antidepressant response to citalopram and maprotiline. A preliminary study.
    Møller SE; de Beurs P; Timmerman L; Tan BK; Leijnse-Ybema HJ; Stuart MH; Petersen HE
    Psychopharmacology (Berl); 1986; 88(1):96-100. PubMed ID: 3080781
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Maprotiline and doxepin in the treatment of depression. A double-glind multicentre comparison.
    Väisänen E; Naarala M; Kontiainen H; Meriläinen V; Heikkilä L; Malinen L
    Acta Psychiatr Scand; 1978 Mar; 57(3):193-201. PubMed ID: 347885
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.